Original language | English |
---|---|
Journal | BMC Cancer |
Publication status | Accepted/In press - 22 Oct 2022 |
Venetoclax combined with low dose cytarabine compared to standard of care intensive chemotherapy for the treatment of favourable risk adult acute myeloid leukaemia (VICTOR): Study protocol for an international, open-label, multicentre, molecularly-guided randomised, phase II trial
Research output: Contribution to journal › Article › peer-review
65
Downloads
(Pure)